Aug 23, 2019

Ruth Bader Ginsburg finishes 3 weeks of radiation therapy

Justice Ruth Bader Ginsburg poses for a photo on Nov. 30, 2018. Photo: Mandel Ngan/AFP/Getty Images

Justice Ruth Bader Ginsburg completed a 3-week course of radiation therapy in New York, the U.S. Supreme Court disclosed on Friday per an NPR report.

What's happening: Ginsburg's outpatient treatment began Aug. 5 to treat a malignant tumor on her pancreas. "The Justice tolerated the treatment well," per a U.S. Supreme Court press release. During the treatment, she managed to maintain an "active schedule," other than missing her annual summer visit to Santa Fe, New Mexico. Physicians at Memorial Sloan Kettering Cancer Center in New York said tests provided no further evidence of the disease spreading to other parts of her body, according to NPR.

Background: Ginsburg, 86, received treatment in December 2018 for lung cancer. She is a 2-time cancer survivor, having battled the disease off and on for nearly 20 years.

Go deeper: Ginsburg to miss Supreme Court oral arguments for the first time

Go deeper

"Jeopardy!" host Alex Trebek to undergo another round of chemotherapy

"Jeopardy!" host Alex Trebek has stage 4 pancreatic cancer. Photo: Santiago Felipe/Getty Images

“Jeopardy!” host Alex Trebek announced Tuesday on "Good Morning America" that he will undergo another round of chemotherapy for stage 4 pancreatic cancer, a month after returning to work and telling fans that he's "on the mend."

Why it matters: Despite overall cancer survival rates improving in the U.S., pancreatic cancer is known to be very deadly and tends to be diagnosed at a more advanced stage.

Go deeperArrowSep 17, 2019

Supreme Court to allow Trump administration to enforce asylum restrictions

Photo: Jonathan Newton / The Washington Post via Getty Images

The Supreme Court on Wednesday lifted a district court's block on a Trump administration rule that would prevent almost all Central American migrants from applying for asylum in the U.S.

The big picture: The Trump rule, first introduced in July, forces migrants fleeing their home countries to apply for asylum in one of the first countries they pass through, or face ineligibility for asylum once they reach the southern border of the U.S. It has faced numerous legal challenges and was twice temporarily blocked by a California judge.

Go deeperArrowSep 11, 2019

CRISPR gene editing used to treat patient with cancer and HIV

Illustration: Rebecca Zisser/Axios

Chinese researchers used CRISPR technology to safely treat a man with cancer and HIV, Bloomberg reports, a major step forward for the gene editing field.

Why it matters: "The man's medical case, published Wednesday in the New England Journal of Medicine, is the first detailed report in a major academic journal of how doctors are using the experimental tool [CRISPR] to manipulate the DNA of a living patient in an effort to cure disease," Bloomberg writes.

Go deeperArrowSep 12, 2019